Metastatic Gastric Adenocarcinoma Recruiting Phase 3 Trials for Capecitabine (DB01101)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04248452Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyTreatment